Nifty 50 November Futures contract can trade in a range of 24,100-24,500

Support at ₹234-₹233 can halt the fall and keep the broader uptrend intact

Brand new design, Cancelled Touch ID, Sony camera sensor, and more.

Jharkhand Vidhan Sabha Chunav 2024: A total of 1.37 crore voters out of the total 2,60 crore are eligible to participate in the voting on November 13. 

Trump will have future opportunities to appoint or replace at least one Fed governor and possibly impact other key leadership roles, but the central bank’s independence remains a core principle

Arundhati Bhattacharya joins John Xavier to discuss the challenge of deploying cloud-based AI applications in public sector banks in India.

The Canadian government is ordering the dissolution of TikTok’s Canadian business after a national security review of the Chinese company behind the social media app but said it won’t block access

However, the pause option can be used only within that day

Canva, the popular graphic design platform, faced a temporary outage that affected users worldwide

Facebook and Instagram users in Europe will get the option to see less personalised ads if they don’t want to pay for an ad-free subscription

The pair hopes to stimulate the immune system to tackle tumors bearing mutant KRas proteins, one of cancer’s toughest targets

Using a multitude of methods, chemists make unprecedented crowded alkyl amines; but one elusive target remains out of reach

Key enzymes in complex biosynthesis could enable alkaloid production

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it

‘Brain gain’ program brings high-profile international researchers to Canadian universities

The start-up, based on the work of Broad Institute scientist Aviv Regev, has raised $65 million to develop therapies for cancer and autoimmune disease

With $40 million series A funding, the start-up will develop inhibitors of proteins that make chemical modifications to RNA

Business is booming, but the industry is handicapped by shifting rules and major research gaps

Flush with another $300 million, Grail plans to enroll 135,000 people in studies this year to detect circulating tumor-derived DNA

Goal is getting Pfizer-owned land in New Jersey back into use

Dynamic boron-oxygen networks are key to the new material’s unusual properties

A new report from the Cancer Research Institute highlights the U.S. and China as cell therapy leaders

With so many ingredients on hand, can the oncology community figure out how to sensibly and efficiently combine checkpoint inhibitors with other drugs?

Goal is getting Pfizer-owned land in New Jersey back into use

Added surface glycine residues cause partial unfolding that adapts enyzyme to low temperatures

The drug company is partnering with Calibr to develop universal CAR T-cells directed to different tumors via antibody switches

Water loss from the gypsum crystal surfaces is a primary degradation pathway

Study shows how stopping one enzyme could help drugs treat an important class of cancers more effectively

News reports linking the gene-editing technology to cancer are the latest in a series of hyped alarms due to be tested in humans soon

The drug company is partnering with Calibr to develop universal CAR T cells directed to different tumors via antibody switches

Water loss from the gypsum crystal surfaces is a primary degradation pathway

Actions may include requiring industry to demonstrate safety of substances, akin to Europe’s REACH program

His efforts to weaken pollution controls expected to endure

Chemical educator and Compound Interest blogger Andy Brunning probes the molecular makeup of the molten rock and gases spewed by volcanoes

His efforts to weaken pollution controls expected to endure

Some coauthors dissent from withdrawal of report, for which key findings have been independently confirmed